BACKGROUND: Vascular calcification has been recognized as a risk factor for cardiovascular (CV) events in patients with end-stage renal disease (ESRD). However, the association of carotid artery calcification (CAAC) with CV events remains unknown. The aim of this study was to elucidate whether CAAC is associated with composite CV events in ESRD patients. METHODS: One-hundred thirty-three patients who had been started on hemodialysis between 2004 and 2008 were included in this retrospective cohort study. These patients received multi-detector computed tomography to assess CAAC at the initiation of hemodialysis. Composite CV events, including ischemic heart disease, heart failure, cerebrovascular diseases, and CV deaths after the initiation of hemodialysis, were examined in each patient. RESULTS: CAAC was found in 94 patients (71%). At the end of follow-up, composite CV events were seen in 47 patients: ischemic heart disease in 20, heart failure in 8, cerebrovascular disease in 12, and CV deaths in 7. The incidence of CAAC was 87% in patients with CV events, which was significantly higher than the rate (62%) in those without. Kaplan-Meier analysis showed a significant increase in composite CV events in patients with CAAC compared with those without CAAC (p = 0.001, log-rank test). Univariate analysis using a Cox hazards model showed that age, smoking, common carotid artery intima-media thickness and CAAC were risk factors for composite CV events. In multivariate analysis, only CAAC was a significant risk factor for composite CV events (hazard ratio, 2.85; 95% confidence interval, 1.18-8.00; p = 0.02). CONCLUSIONS: CAAC is an independent risk factor for CV events in ESRD patients. The assessment of CAAC at the initiation of hemodialysis is useful for predicting the prognosis.
BACKGROUND:Vascular calcification has been recognized as a risk factor for cardiovascular (CV) events in patients with end-stage renal disease (ESRD). However, the association of carotid artery calcification (CAAC) with CV events remains unknown. The aim of this study was to elucidate whether CAAC is associated with composite CV events in ESRDpatients. METHODS: One-hundred thirty-three patients who had been started on hemodialysis between 2004 and 2008 were included in this retrospective cohort study. These patients received multi-detector computed tomography to assess CAAC at the initiation of hemodialysis. Composite CV events, including ischemic heart disease, heart failure, cerebrovascular diseases, and CV deaths after the initiation of hemodialysis, were examined in each patient. RESULTS:CAAC was found in 94 patients (71%). At the end of follow-up, composite CV events were seen in 47 patients: ischemic heart disease in 20, heart failure in 8, cerebrovascular disease in 12, and CV deaths in 7. The incidence of CAAC was 87% in patients with CV events, which was significantly higher than the rate (62%) in those without. Kaplan-Meier analysis showed a significant increase in composite CV events in patients with CAAC compared with those without CAAC (p = 0.001, log-rank test). Univariate analysis using a Cox hazards model showed that age, smoking, common carotid artery intima-media thickness and CAAC were risk factors for composite CV events. In multivariate analysis, only CAAC was a significant risk factor for composite CV events (hazard ratio, 2.85; 95% confidence interval, 1.18-8.00; p = 0.02). CONCLUSIONS:CAAC is an independent risk factor for CV events in ESRDpatients. The assessment of CAAC at the initiation of hemodialysis is useful for predicting the prognosis.
Authors: Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Carmine Zoccali Journal: J Am Soc Nephrol Date: 2001-11 Impact factor: 10.121
Authors: Sharon M Moe; Kalisha D O'Neill; Danxia Duan; Sadiq Ahmed; Neal X Chen; Stephen B Leapman; Naomi Fineberg; Kenyon Kopecky Journal: Kidney Int Date: 2002-02 Impact factor: 10.612
Authors: T Haraki; T Takegoshi; C Kitoh; K Kajinami; T Wakasugi; J Hirai; T Shimada; M Kawashiri; A Inazu; J Koizumi; H Mabuchi Journal: Clin Nephrol Date: 2001-08 Impact factor: 0.975
Authors: Francis Verbeke; Wim Van Biesen; Eero Honkanen; Björn Wikström; Per Bruno Jensen; Jean-Marie Krzesinski; Merete Rasmussen; Raymond Vanholder; Pieter L Rensma Journal: Clin J Am Soc Nephrol Date: 2010-09-09 Impact factor: 8.237
Authors: Ahmed F Elhabashi; Leena Sulaibeekh; Nahed Seddiq; Salman Alali; Amjad K Abdulmajeed; Nuria S Perez Journal: Risk Manag Healthc Policy Date: 2020-08-03
Authors: Samantha J Borland; Thomas G Morris; Shona C Borland; Mark R Morgan; Sheila E Francis; Catherine L R Merry; Ann E Canfield Journal: Cardiovasc Res Date: 2017-11-01 Impact factor: 10.787